Expression of 14-3-3 ζ and interaction with protein kinase C in the rat retina in early diabetes

Diabetologia

Volumn 48, Issue 7, 2005, Pages 1411-1415

  Kim, Y H ^a   Kim, Y S ^a   Kang, S S ^a   Noh, H S ^a   Kim, H J ^a   Cho, G J ^a   Choi, W S ^a,b  

^a Gyeongsang National University   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

14 3 3 ; Diabetes; PKC activation; Retina; Streptozotocin

Indexed keywords

PROTEIN 14 3 3 ZETA; PROTEIN KINASE C; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETIC RETINOPATHY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; WESTERN BLOTTING;

14-3-3 PROTEINS; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; MALE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 23944474255     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1774-7     Document Type: Article

References (24)

1. Hashiguchi M, Sobue K, Paudel HK (2000) 14-3-3zeta is an effector of tau protein phosphorylation. J Biol Chem 275: 25247-25254
2. Agarwal-Mawal A, Qureshi HY, Cafferty PW et al (2003) 14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem 278:12722-12728
3. Rubio MP, Geraghty KM, Wong BH et al (2004) 14-3-3-Affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J 379:395-408
4. Umahara T, Uchihara T, Tsuchiya K et al (2004) 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol (Berl) 108:279-286
5. Gannon-Murakami L, Murakami K (2002) Selective association of protein kinase C with 14-3-3 zeta in neuronally differentiated PC12 cells. Stimulatory and inhibitory effect of 14-3-3 zeta in vivo. J Biol Chem 277:23116-23122
6. Martin H, Rostas J, Patel Y, Aitken A (1994) Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 63:2259-2265
7. Kockel L, Vorbruggen G, Jackle H, Mlodzik M, Bohmann D (1997) Requirement for Drosophila 14-3-3 zeta in Raf-dependent photoreceptor development. Genes Dev 11:1140-1147
8. Rommel C, Radziwill G, Moelling K, Hafen E (1997) Negative regulation of Raf activity by binding of 14-3-3 to the amino terminus of Raf in vivo. Mech Dev 64:95-104
9. Van Der Hoeven PC, Van Der Wal JC, Ruurs P, Van Dijk MC, Van Blitterswijk J (2000) 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation. Biochem J 345:297-306
10. Van Der Hoeven PC, Van Der Wal JC, Ruurs P, Van Blitterswijk WJ (2000) Protein kinase C activation by acidic proteins including 14-3-3. Biochem J 347:781-785
11. Meller N, Liu YC, Collins TL et al (1996) Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function. Mol Cell Biol 16:5782-5791
12. Wheeler-Jones CP, Learmonth MP, Martin H, Aitken A (1996) Identification of 14-3-3 proteins in human platelets: effects of synthetic peptides on protein kinase C activation. Biochem J 315:41-47
13. Matto-Yelin M, Aitken A, Ravid S (1997) 14-3-3 inhibits the Dictyostelium myosin II heavy-chain-specific protein kinase C activity by a direct interaction: identification of the 14-3-3 binding domain. Mol Biol Cell 8:1889-1899
14. Aitken A, Howell S, Jones D et al (1995) Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol Cell Biochem 149-150:41-49
15. Birch KA, Heath WF, Hermeling RN et al (1996) LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes 45:642-650
16. Oku H, Kodama T, Sakagami K, Puro DG (2001) Diabetes-induced disruption of gap junction pathways within the retinal microvasculature. Invest Ophthalmol Vis Sci 42:1915-1920
17. Wigg SJ, Tare M, Forbes J et al (2004) Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia 47:1038-1046
18. Kunisaki M, Bursell SE, Clermont AC et al (1995) Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269: E239-E246
19. Bursell SE, Takagi C, Clermont AC et al (1997) Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. Invest Ophthalmol Vis Sci 38:2711-2720
20. Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866
21. Kim YS, Kim YH, Cheon EW et al (2003) Retinal expression of clusterin in the streptozotocin-induced diabetic rat. Brain Res 976:53-59
22. Kim YH, Kim YS, Noh HS et al (2005) Change of rhodopsin kinase and transducin in the rat retina at early stage of diabetes. Exp Eye Res (in press)
23. Aitken A (1996) 14-3-3 and its possible role in co-ordinating multiple signalling pathways. Trends Cell Biol 6:341-347
24. Birch KA, Heath WF, Hermeling RN et al (1996) LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes 45:642-650